This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lay Line Genomics S.p.a.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Fabio Benigni in Antibody Development
Introduction
Fabio Benigni is a notable inventor based in Rome, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various therapeutic applications, showcasing the potential of innovative solutions in medicine.
Latest Patents
Benigni holds a patent for "Antibodies and derivatives thereof." This patent includes an anti-TrkA antibody, which is designed to target specific biological pathways. The innovation represented by this patent highlights the advancements in antibody technology and its potential impact on treatment methodologies.
Career Highlights
Throughout his career, Fabio Benigni has been associated with Lay Line Genomics S.p.a., a company focused on genomic research and development. His role in the company has allowed him to contribute to groundbreaking research in the field of antibodies and their applications.
Collaborations
Benigni has collaborated with several professionals in his field, including Daniele D'Ambrosio and Daniele D'AMBROSIO. These collaborations have fostered a productive environment for innovation and research, leading to advancements in their shared areas of expertise.
Conclusion
Fabio Benigni's work in antibody development exemplifies the importance of innovation in biotechnology. His contributions continue to influence the field and pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile